ERT launches patient-administered ECG assessment
The technology enables sponsors to continue gathering cardiac data for clinical trials without interruption or risk to patient safety.
The technology enables sponsors to continue gathering cardiac data for clinical trials without interruption or risk to patient safety.
The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners.
Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus.